NO171499C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivaterInfo
- Publication number
- NO171499C NO171499C NO852741A NO852741A NO171499C NO 171499 C NO171499 C NO 171499C NO 852741 A NO852741 A NO 852741A NO 852741 A NO852741 A NO 852741A NO 171499 C NO171499 C NO 171499C
- Authority
- NO
- Norway
- Prior art keywords
- thiofen
- penta
- cyclo
- dihydro
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8410861A FR2567125B1 (fr) | 1984-07-09 | 1984-07-09 | Acides dihydro-5,6-4h-cyclopenta (b) thiophenecarboxylique-6, procedes de preparation et medicaments les contenant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO852741L NO852741L (no) | 1986-01-10 |
| NO171499B NO171499B (no) | 1992-12-14 |
| NO171499C true NO171499C (no) | 1993-03-24 |
Family
ID=9305925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO852741A NO171499C (no) | 1984-07-09 | 1985-07-08 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4649153A (de) |
| EP (1) | EP0172041B1 (de) |
| JP (1) | JPH072733B2 (de) |
| AR (1) | AR242381A1 (de) |
| AT (1) | ATE36329T1 (de) |
| AU (1) | AU573147B2 (de) |
| CA (1) | CA1249834A (de) |
| CS (1) | CS255887B2 (de) |
| DD (1) | DD235454A5 (de) |
| DE (1) | DE3564268D1 (de) |
| DK (1) | DK161321C (de) |
| ES (1) | ES8604550A1 (de) |
| FR (1) | FR2567125B1 (de) |
| GR (1) | GR851609B (de) |
| HU (1) | HU202519B (de) |
| IE (1) | IE58362B1 (de) |
| IL (1) | IL75527A (de) |
| IN (1) | IN166471B (de) |
| MA (1) | MA20481A1 (de) |
| MX (1) | MX162258A (de) |
| NO (1) | NO171499C (de) |
| NZ (1) | NZ212619A (de) |
| OA (1) | OA08076A (de) |
| SU (1) | SU1402261A3 (de) |
| YU (1) | YU113885A (de) |
| ZA (1) | ZA854519B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4692460A (en) * | 1986-12-24 | 1987-09-08 | Mcneilab, Inc. | Cyclopenta[b]thiophenes having anti-inflammatory activity similar to steroids |
| IL103106A (en) * | 1991-09-25 | 1998-06-15 | Sanofi Elf | Sites of tynocyclopentanone oximes, their preparation and pharmaceutical preparations containing them |
| US8106046B2 (en) * | 2008-06-24 | 2012-01-31 | Bristol-Myers Squibb Company | Cyclopentathiophene modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| RU2661151C1 (ru) * | 2017-12-14 | 2018-07-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2167334A1 (en) * | 1972-01-13 | 1973-08-24 | Roussel Uclaf | 4-aroyl-5-alkylthiophene-2-acetic acids - with analgesic and antiinflammatory activity |
| DK464274A (de) * | 1973-09-11 | 1975-05-12 | Sandoz Ag |
-
1984
- 1984-07-09 FR FR8410861A patent/FR2567125B1/fr not_active Expired
-
1985
- 1985-06-11 DE DE8585401139T patent/DE3564268D1/de not_active Expired
- 1985-06-11 AT AT85401139T patent/ATE36329T1/de not_active IP Right Cessation
- 1985-06-11 EP EP85401139A patent/EP0172041B1/de not_active Expired
- 1985-06-13 AU AU43625/85A patent/AU573147B2/en not_active Ceased
- 1985-06-14 IE IE148685A patent/IE58362B1/en not_active IP Right Cessation
- 1985-06-14 IL IL75527A patent/IL75527A/xx not_active IP Right Cessation
- 1985-06-14 ZA ZA854519A patent/ZA854519B/xx unknown
- 1985-06-20 US US06/746,785 patent/US4649153A/en not_active Expired - Fee Related
- 1985-06-27 CA CA000485580A patent/CA1249834A/fr not_active Expired
- 1985-07-01 GR GR851609A patent/GR851609B/el unknown
- 1985-07-02 NZ NZ212619A patent/NZ212619A/en unknown
- 1985-07-04 MA MA20706A patent/MA20481A1/fr unknown
- 1985-07-05 MX MX8652A patent/MX162258A/es unknown
- 1985-07-05 AR AR85300926A patent/AR242381A1/es active
- 1985-07-08 HU HU852639A patent/HU202519B/hu not_active IP Right Cessation
- 1985-07-08 JP JP60148462A patent/JPH072733B2/ja not_active Expired - Lifetime
- 1985-07-08 NO NO852741A patent/NO171499C/no unknown
- 1985-07-08 SU SU853917559A patent/SU1402261A3/ru active
- 1985-07-08 DK DK310685A patent/DK161321C/da not_active IP Right Cessation
- 1985-07-08 ES ES544961A patent/ES8604550A1/es not_active Expired
- 1985-07-08 OA OA58634A patent/OA08076A/xx unknown
- 1985-07-08 CS CS855107A patent/CS255887B2/cs unknown
- 1985-07-09 YU YU01138/85A patent/YU113885A/xx unknown
- 1985-07-09 DD DD85278415A patent/DD235454A5/de not_active IP Right Cessation
- 1985-08-02 IN IN630/DEL/85A patent/IN166471B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
| NO851949L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater. | |
| NO170480C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater | |
| NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
| NO162514C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater. | |
| NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
| NO170155C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater | |
| NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
| NO166080C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner. | |
| NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO167916C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater | |
| NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
| NO170976C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater | |
| NO171909C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
| NO850564L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive (2-okso-1,2,3,5-tetrahydroimidazo 2,1-b kinazolinyl) oksyalkylamider | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO164982C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO165069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere. | |
| NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
| NO891114D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
| NO164895C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO171108C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater | |
| NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. |